Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The first component of human complement (C1): activation and control.

R J Ziccardi

    Springer Seminars in Immunopathology
    |January 1, 1983
    PubMed
    Summary

    The human complement component C1, crucial for immune response, requires metal ions for stability. C1-inhibitor regulates C1 activation, preventing excessive complement activity and potentially hereditary angioedema.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Studies on the mechanism of C3b inhibition of immune complex induced C1 activation.

    Molecular immunology·1988
    Same author

    Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.

    Journal of immunology (Baltimore, Md. : 1950)·1986
    Same author

    Nature of the interaction between the C1q and C1r2S2 subunits of the first component of human complement.

    Molecular immunology·1985
    Same author

    Demonstration of the interaction of native C1 with monomeric immunoglobulins and C1 inhibitor.

    Journal of immunology (Baltimore, Md. : 1950)·1985
    Same author

    Characterization of the interaction of human C4b-binding protein with physiological ligands.

    The Journal of biological chemistry·1984
    Same author

    Antibody-independent C1 activation by E. coli.

    Journal of immunology (Baltimore, Md. : 1950)·1984

    Area of Science:

    • Immunology
    • Biochemistry
    • Molecular Biology

    Background:

    • The first component of human complement (C1) is a large glycoprotein essential for initiating the complement cascade.
    • C1 exists as a precursor and requires activation to gain enzymatic activity against substrates C2 and C4.
    • Activation can be triggered by immune complexes or non-immune substances, and also occurs spontaneously.

    Purpose of the Study:

    • To elucidate the structure, function, and regulation of the human complement component C1.
    • To investigate the role of C1-inhibitor (C1-In) in controlling C1 activation and its implications in disease.

    Main Methods:

    • Analysis of C1 structure and subunit interactions (C1q and C1r2s2).
    • Investigation of C1 activation mechanisms, including immune complex-induced, non-immune-induced, and spontaneous pathways.
    • Characterization of C1-inhibitor's inhibitory functions on C1 enzymatic activities and activation processes.

    Main Results:

    • C1 requires calcium or other metal ions for structural integrity and function.
    • C1-inhibitor effectively blocks C1 enzymatic activity and regulates both spontaneous and non-immune-induced C1 activation.
    • Low C1-inhibitor levels may lead to excessive C1 autoactivation, contributing to complement dysregulation in hereditary angioedema.

    Conclusions:

    • C1-inhibitor is a critical regulator of the classical complement pathway, controlling nonspecific activation.
    • Dysregulation of C1 activation by C1-inhibitor is implicated in the pathogenesis of hereditary angioedema.
    • C1 possesses functions beyond initiating the complement cascade, warranting further investigation.

    Related Experiment Videos